Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

por Lavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., Meininger, G.
Publicado 2013

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

por Stenlöf, K, Cefalu, W T, Kim, K-A, Alba, M, Usiskin, K, Tong, C, Canovatchel, W, Meininger, G
Publicado 2013

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Di...

por Schernthaner, G, Gross, JL, Rosenstock, J, Guarisco, M, Fu, M, Yee, J, Kawaguchi, M, Canovatchel, W, Meininger, G
Publicado 2013

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

por Wilding, J P H, Charpentier, G, Hollander, P, González-Gálvez, G, Mathieu, C, Vercruysse, F, Usiskin, K, Law, G, Black, S, Canovatchel, W, Meininger, G
Publicado 2013